Seyed Abootorabi M, Nourisaeidlou S, Behroozi Lak T, Ayremlou P. The Effect of Vitamin D Supplementation on Insulin Resistance in Vitamin D Deficient Women with Poly-cystic Ovary Syndrome: A Randomized, Placebo-Controlled Clinical Trial. , Iran South Med J. 2026; 29 (6) :372-388
URL:
http://ismj.bpums.ac.ir/article-1-2710-en.html
1- Department of Nutrition, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran
2- Food and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran , nourisaeidlou_s@umsu.ac.ir
3- Reproductive Health Research Center, Department of Infertility, Urmia University of Medical Sciences, Urmia, Iran
4- Clinical Research,Development Unit of Imam Khomeini Hospital, Urmia University of Medical Sciences, Urmia, Iran
Abstract: (16 Views)
Background: Polycystic ovary syndrome (PCOS) is the most common cause of ovarian dysfunction in women of reproductive age. Hyperinsulinemia and insulin resistance are hallmark metabolic disturbances in the majority of women with PCOS. This study aimed to evaluate the effect of vitamin D oral supplementation on insulin resistance in vitamin D-deficient women with PCOS.
Materials and Methods: In this randomized, placebo-controlled clinical trial, 44 women with PCOS aged 20–38 years and plasma 25OHD < 20 ng/mL were randomized to the intervention or placebo group and were followed for 8 weeks. Participants received 50,000 IU of oral vitamin D3 once weekly in the intervention group or placebo. Indices of insulin resistance, including HOMA-IR, HOMA-β, and QUICKI, were compared within each group before and after the intervention.
Results: Of the 44 randomized participants, 36 (81.8%) completed the study. After eight weeks of intervention, significant differences were observed between the two groups in terms of fasting blood sugar and vitamin D levels (P = 0.001 and P < 0.001, respectively). The mean fasting blood sugar in the intervention group decreased significantly from 86.74 ± 6.76 mg/dl before the intervention to 79.06 ± 7.09mg/dl after the intervention (P = 0.001), whereas the change in the control group was not significant (before: 84.18 ± 5.85 g/dl; after: 85.91 ± 7.92 g/dl; P = 0.185). The serum vitamin D levels in the intervention group increased significantly from 8.65 ± 4.13 before the intervention to 36.9 ± 8.38 (P = 0.001), and the amount of vitamin D in the control group also increased significantly from 9.81 ± 5.12 before the intervention to 13.35 ± 7.11 (P = 0.003). The mean HOMA-β index in the intervention group increased significantly from 220.7 ± 102.64 before the intervention to 350.4 ± 110.44 after the intervention (P = 0.001). In contrast, the change in the control group was not statistically significant (P = 0.339). Furthermore, after adjusting for baseline values in the ANCOVA analysis, the inter-group difference in HOMA-β after the intervention was statistically significant (P = 0.047). Changes in the other indices, including fasting insulin, HOMA-IR, and QUICKI, were not statistically significant within either group or between the two groups (P > 0.05).
Conclusion: Vitamin D supplementation in women with PCOS and vitamin D deficiency was associated with a significant increase in HOMA-β, accompanied by a significant reduction in fasting blood glucose and an increase in serum vitamin D levels.
Original:
Original |
Subject:
Science and nutrition Received: 1901/12/14 | Accepted: 1901/12/14 | Published: 2026/11/21
Send email to the article author